MCTs, especially MCT1 and MCT4, were important contributors to tumor aggressiveness and poor prognosis [38], which had been verified in colorectal carcinoma [39], gastric carcinoma [40], and esophageal adenocarcinomas [41]. The gene discussed is SLC16A4; the disease is gastric carcinoma.